Hemab Therapeutics Holdings, Inc. Common Stock (COAG) vs Innovage Holding Corp. (INNV)
A side-by-side comparison of Hemab Therapeutics Holdings, Inc. Common Stock and Innovage Holding Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
COAG
Hemab Therapeutics Holdings, Inc. Common Stock
$28.94HealthcareDelayed quote: Oct 6, 2026, 12:25 PM EDT
INNV
Innovage Holding Corp.
$8.97HealthcareDelayed quote: Oct 6, 2026, 12:25 PM EDT
Total return — COAG vs INNV
growth of $100 · dividends reinvested · last 1yCOAG -10.0% (-10.0%/yr)INNV +8.2% (+8.2%/yr)INNV compounded faster over this window
COAG INNV
COAG vs INNV: by the numbers
- •COAG is the larger company ($1.35B vs $1.22B market cap).
- •Both run net losses; COAG's is the smaller (0.00% vs -0.26% net margin).
Metrics side by side
Valuation
| Metric | COAG | INNV |
|---|---|---|
| Forward P/E | N/A | 20.37 |
| P/S ratio | N/A | 1.23 |
| P/B ratio | 2.98 | 5.17 |
| EV / EBITDA | N/A | 14.30 |
| FCF yield | N/A | 4.15% |
Profitability
| Metric | COAG | INNV |
|---|---|---|
| Gross margin | 0.00% | 21.39% |
| Operating margin | 0.00% | 6.39% |
| Net margin | 0.00% | -0.26% |
| ROE | N/A | -1.08% |
| ROIC | -38.09% | 9.48% |
Growth (annualized)
| Metric | COAG | INNV |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 9.19% |
| Total return CAGR (5Y) | N/A | 5.55% |
Go deeper
Dig into the metrics
Hemab Therapeutics Holdings, Inc. Common Stock ROEInnovage ROEHemab Therapeutics Holdings, Inc. Common Stock operating marginInnovage operating marginHemab Therapeutics Holdings, Inc. Common Stock revenue growthInnovage revenue growthHemab Therapeutics Holdings, Inc. Common Stock free cash flowInnovage free cash flow
Hemab Therapeutics Holdings, Inc. Common Stock & Innovage appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.